2025 Regular Session • Maryland Legislature
SB646: Health Insurance - Insulin - Prohibition on Step Therapy or Fail-First Protocols
Legislative Summary
Prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from imposing a step therapy or fail-first protocol for insulin or an insulin analog used to treat an insured's or enrollee's diabetes.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/29/2025
First Reading Finance
Senate
2/6/2025
Hearing 2/26 at 1:00 p.m.
Senate
3/31/2025
Favorable with Amendments Report by Finance
Senate
3/31/2025
Favorable with Amendments {493829/1 Adopted
Senate
3/31/2025
Second Reading Passed with Amendments
Senate
4/1/2025
Third Reading Passed (46-0)
Senate
4/2/2025
Referred Rules and Executive Nominations
House of Delegates
4/2/2025
Rereferred to Health and Government Operations
House of Delegates
4/4/2025
Favorable Report by Health and Government Operations
House of Delegates
4/4/2025
Favorable Adopted Second Reading Passed
House of Delegates
4/7/2025
Third Reading Passed (137-0)
House of Delegates
4/7/2025
Returned Passed
Senate
Amendments
Favorable with Amendments 493829/1 Adopted
Favorable with Amendments 493829/1 Adopted
3/31/2025Adopted
Roll Call Votes
Third Reading Passed
4/7/2025
137
Yea
0
Nay
4
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Enrolled(4/7/2025)
Chamber
Senate
Sponsors
Democrat: 1
Primary Sponsor
Anthony Muse
Democrat